Skip to main content

Table 1 Characteristics of control and AD subjects examined in this study

From: Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease

Case # Age (y) Gender Diagnosis Disease duration (y) ApoE genotype PMI (h) Braak stage
C1 76 F Control NA 3/3 24 1
C2 80 F Control NA 2/4 54 1
C3 76 M Control NA 3/4 48 1
C4 89 F Control NA 2/3 13 2
C5 91 F Control NA 3/3 19 2
C6 71 M Control NA NA 5 0
C7 87 M Control NA NA 36 1
A1 85 F AD 4 3/4 10 5
A2 73 F AD 19 3/3 14 5
A3 84 F AD 16 3/4 12 5
A4 92 M AD 22 4/4 12 5
A5 83 F AD 13 3/4 12 5
A6 82 M AD 6 3/4 7 6
A7 91 F AD 14 3/4 9 5
A8 95 M AD NA 3/3 11 6
  1. NA = not applicable or not available; PMI = postmortem interval.